Shared on15 Jul 25Fair value Increased 10%
Despite lower consensus revenue growth forecasts, MedPlus Health Services’ sharply improved net profit margin has driven a notable increase in the consensus analyst price target from ₹965.39 to ₹1064. Valuation Changes Summary of Valuation Changes for MedPlus Health Services The Consensus Analyst Price Target has significantly risen from ₹965.39 to ₹1064.
Shared on01 May 25Fair value Decreased 0.47%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 0.87%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on13 Mar 25Fair value Decreased 9.63%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.